Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up

• Những tác giả chính: Yong Hoon Kim (Tác giả), Ae-Young Her (Tác giả), Seung-Woon Rha (Tác giả), Byoung Geol Choi (Tác giả), Se Yeon Choi (Tác giả), Jae Kyeong Byun (Tác giả), Yoonjee Park (Tác giả), Dong Oh Kang (Tác giả), Won Young Jang (Tác giả), Woohyeun Kim (Tác giả), Cheol Ung Choi (Tác giả), Chang Gyu Park (Tác giả), Hong Seog Seo (Tác giả)
• Định dạng: Sách
• Được phát hành: Ubiquity Press, 2020-02-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Background: Endeavor®-zotarolimus-eluting stent (E-ZES) was the first ZES to be developed, and Resolute integrity®-ZES (I-ZES) has been developed more recently. Comparative studies on long-term usage of these two ZESs have been rare. Objectives: The aim of this study was to compare the efficacy and...